Insel Gruppe AG

Research activity includes acute ischemic stroke care, with interest in patients who have residual occlusion after mechanical thrombectomy and in those receiving intravenous thrombolysis despite recent direct oral anticoagulant use. The clinical focus extends to improving neurological recovery and treatment safety in complex stroke presentations.

• Tenecteplase
• Thrombolysis after thrombectomy
• Direct oral anticoagulants

Additional interest lies in optimizing reperfusion strategies when standard treatment pathways are constrained by prior anticoagulant exposure or incomplete vessel reopening.